Novartis Aktie
112,60
EUR
-0,65
EUR
-0,57
%
104,08
CHF
-0,44
CHF
-0,42
%
Werbung
Novartis Aktie Analyse
| 22.06.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 22.06.22 | Novartis Sell | Deutsche Bank AG | |
| 27.04.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 27.04.22 | Novartis Sell | Deutsche Bank AG | |
| 26.04.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 22.04.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 05.04.22 | Novartis Sell | Deutsche Bank AG | |
| 04.04.22 | Novartis Underweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 01.04.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 03.03.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 03.02.22 | Novartis Sell | Deutsche Bank AG | |
| 02.02.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 02.02.22 | Novartis Underweight | Barclays Capital | |
| 01.02.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 31.01.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 31.01.22 | Novartis Underweight | Barclays Capital | |
| 20.01.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 12.01.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 04.01.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 20.12.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 17.12.21 | Novartis Sell | Deutsche Bank AG | |
| 16.12.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 06.12.21 | Novartis Sell | Deutsche Bank AG | |
| 03.12.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 04.11.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 27.10.21 | Novartis Underweight | Barclays Capital | |
| 27.10.21 | Novartis Sell | Deutsche Bank AG | |
| 27.10.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 26.10.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 26.10.21 | Novartis Sell | Deutsche Bank AG | |
| 25.10.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 05.10.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 20.09.21 | Novartis Sell | Deutsche Bank AG | |
| 14.09.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 28.07.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 21.07.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 20.07.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 06.07.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 04.06.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 21.05.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 19.05.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 28.04.21 | Novartis Underweight | Barclays Capital | |
| 28.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 27.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 27.04.21 | Novartis Underweight | Barclays Capital | |
| 22.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 09.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 07.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 23.03.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 03.02.21 | Novartis Underweight | JP Morgan Chase & Co. | |
Werbung
Werbung